A new diet pill Contrave got approval to be sold in the United States on Wednesday, only the third obesity treatment in more than a decade to win approval from the Food and Drug Administration.
Made by Orexigen Therapeutics Inc, Contrave is a combination of the antidepressant bupropion and Orexigen's formulation of naltrexone, designed to prevent drug dependence.
11:01 Why Yahoo CEO Marissa Mayer’s $141 Million Payday Is Safe From the Hack Cover-Up15
23:37 Here’s Why Netflix’s Share Price Just Hit a New All-Time High11
21:52 Netflix nears 94 million subscribers 10 years after streaming launch21
22:33 Allergan to pay $15 million over failing to disclose merger talks19